Perico N, Benigni A, Bosco E, Rossini M, Orisio S, Ghilardi F, Piccinelli A, Remuzzi G
Clin Nephrol. 1986;25 Suppl 1:S83-8.
Cyclosporine A (CsA) is a recently introduced immunosuppressive agent that represents a significant advance in the clinical control of graft rejection. However despite the remarkable effectiveness, one of the limiting factors to a more extensive use of CsA appears to be its nephrotoxicity. CsA is reported to induce a tubular epithelial damage whereas histological examination of glomeruli does not reveal abnormalities unless particularly high doses of the drug are used. On the other hand a decrease in glomerular filtration rate (GFR) has been reported in association with acute administration of CsA. Relatively few studies are available to compare structural and functional abnormalities in the same animals after an acute administration of CsA. Here we evaluated morphological abnormalities and renal function in the same animals treated for 20 days with CsA. Moreover in the attempt to find a link between tubular damage and decrease in GFR we studied the effect of CsA on the renin-angiotensin system as well as on glomerular synthesis of prostacyclin (PGI2) and prostaglandin E2 (PGE2). Our results confirmed that CsA induces a focal damage of tubular epithelial cells with isometric vacuolization of cytoplasm. No glomerular or vascular changes have been detected at histological examination. Serum creatinine was significantly elevated after 20 days of treatment, whereas creatinine clearance showed a progressive tendency to decrease without reaching a statistical significance. Plasma renin activity was found to progressively increase during CsA administration, whereas the synthesis of PGI2 and PGE2 by isolated glomeruli was not modified in CsA-treated animals in respect to animals receiving the solvent alone.(ABSTRACT TRUNCATED AT 250 WORDS)
环孢素A(CsA)是一种最近引入的免疫抑制剂,它在移植排斥反应的临床控制方面代表了一项重大进展。然而,尽管其效果显著,但CsA更广泛应用的限制因素之一似乎是其肾毒性。据报道,CsA可诱导肾小管上皮损伤,而肾小球的组织学检查未发现异常,除非使用特别高剂量的药物。另一方面,有报道称急性给予CsA会导致肾小球滤过率(GFR)降低。相对较少的研究可用于比较急性给予CsA后同一动物的结构和功能异常。在此,我们评估了用CsA治疗20天的同一动物的形态学异常和肾功能。此外,为了试图找到肾小管损伤与GFR降低之间的联系,我们研究了CsA对肾素 - 血管紧张素系统以及对肾小球前列环素(PGI2)和前列腺素E2(PGE2)合成的影响。我们的结果证实,CsA诱导肾小管上皮细胞的局灶性损伤,伴有细胞质的等张空泡化。组织学检查未发现肾小球或血管变化。治疗20天后血清肌酐显著升高,而肌酐清除率呈逐渐下降趋势,但未达到统计学显著性。发现血浆肾素活性在给予CsA期间逐渐增加,而与仅接受溶剂的动物相比,CsA处理动物中分离肾小球的PGI2和PGE2合成未发生改变。(摘要截短于250字)